Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Treasury Shares (2016 - 2026)

Insmed's Treasury Shares history spans 16 years, with the latest figure at $92219.0 for Q1 2026.

  • Quarterly Treasury Shares changed N/A to $92219.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $92219.0 through Mar 2026, changed N/A year-over-year, with the annual reading at $3.9 million for FY2025, 17.13% up from the prior year.
  • Treasury Shares came in at $92219.0 for Q1 2026, down from $3.9 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $3.9 million in Q4 2025 to a low of $92219.0 in Q1 2026.
  • The 5-year median for Treasury Shares is $266550.0 (2023), against an average of $1.3 million.
  • Year-over-year, Treasury Shares surged 80.95% in 2023 and then fell 0.25% in 2024.
  • Insmed's Treasury Shares stood at $1.5 million in 2022, then surged by 80.95% to $2.8 million in 2023, then increased by 20.73% to $3.3 million in 2024, then increased by 17.13% to $3.9 million in 2025, then plummeted by 97.63% to $92219.0 in 2026.
  • Per Business Quant, the three most recent readings for INSM's Treasury Shares are $92219.0 (Q1 2026), $3.9 million (Q4 2025), and $3.3 million (Q4 2024).